Grant Baxter International Inc Transaction History

Grant

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$37.88 - $43.77 $165,308 - $191,012	-4,364 Reduced 47.42%	4,839 $206,000
Q4 2023 Jan 30, 2024	BUY	$31.71 - $38.95 $291,827 - $358,456	9,203 New	9,203 $355,000
Q3 2022 Nov 02, 2022	SELL	$53.86 - $66.8 $36,517 - $45,290	-678 Reduced 15.51%	3,692 $210,000
Q2 2022 Jul 20, 2022	BUY	$63.83 - $80.0 $63 - $80	1 Added 0.02%	4,370 $282,000
Q1 2022 Apr 25, 2022	BUY	$76.85 - $89.45 $77,234 - $89,897	1,005 Added 29.88%	4,369 $334,000
Q4 2021 Jan 13, 2022	SELL	$74.57 - $87.19 $31,617 - $36,968	-424 Reduced 11.19%	3,364 $290,000
Q2 2021 Aug 05, 2021	BUY	$80.5 - $88.01 $80 - $88	1 Added 0.03%	3,788 $308,000
Q4 2020 Jan 15, 2021	BUY	$75.39 - $82.36 $285,501 - $311,897	3,787 New	3,787 $312,000

1,005

462M

1.8M

2.93M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.4B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Grant, based on Form 13F filings with the SEC.

Stay updated on Grant with notifications on news.